Historical record - last NADAC effective date: 7/1/2021
Product Information
FIRVANQ 25 MG/ML SOLUTION is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $0.4709 per ML under NDC 65628020510. Its NADAC has been published 178 times since Feb 20, 2019.
FDA first approved this application on Jan 26, 2018. Its Orange Book therapeutic-equivalence code is AA.
Manufacturer
Azurity Pharmaceuticals Inc.NDC
65628020510
Classification
Brand
Dosage Form
KIT
Effective Date
7/1/2021
Approval Type
New Drug (NDA)
FDA Application
NDA208910FDA Approved
1/26/2018
TE Code
AA
On Market Since
1/26/2018
Price Statistics
The NADAC for FIRVANQ 25 MG/ML SOLUTION has been published 178 times since Feb 20, 2019, and over the history we have for it it has risen 15.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4709 per ML |
|---|---|
| All-time high | $0.4709 (Jul 13, 2022) |
| All-time low | $0.4086 (Feb 20, 2019) |
| Median price | $0.4510 |
| Average price | $0.4525 |
| Largest weekly change | +9.0% (Apr 3, 2019) |
| Weeks tracked | 178 |
| Tracking since | Feb 20, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
0.0%
All
+15.2%
Last surveyed Jul 13, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Azurity Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
vancomycin hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FIRVANQ 25 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for FIRVANQ 25 MG/ML SOLUTION, manufactured by Azurity Pharmaceuticals Inc., is $0.4709 per ML (NDC 65628020510), effective Jul 13, 2022.
How has the price of FIRVANQ 25 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for FIRVANQ 25 MG/ML SOLUTION has risen 15.2%. It has been tracked across 178 weekly CMS publications since Feb 20, 2019.
What are the highest and lowest recorded NADAC prices for FIRVANQ 25 MG/ML SOLUTION?
Since Feb 20, 2019, the NADAC for FIRVANQ 25 MG/ML SOLUTION has ranged from a low of $0.4086 (Feb 20, 2019) to a high of $0.4709 (Jul 13, 2022), with a median of $0.4510 per ML.
Are there cheaper alternatives to FIRVANQ 25 MG/ML SOLUTION?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VANCOMYCIN 25 MG/ML ORAL SOLN, is $0.3900 per ML — about 17% below FIRVANQ 25 MG/ML SOLUTION.
Who manufactures FIRVANQ 25 MG/ML SOLUTION?
FIRVANQ 25 MG/ML SOLUTION (NDC 65628020510) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.